Bipartisan FDA User Fee Bill Hits Snag On Senate Floor

Law360, New York (May 22, 2012, 6:44 PM EDT) -- The Food and Drug Administration user fee bill hit a snag on the Senate floor Tuesday, when majority leader Harry Reid delayed taking up the bill until both sides agree to limit amendments on the must-pass legislation.

Reid, D-Nevada, pushed back the consideration of the bill and amendments, originally scheduled for Tuesday afternoon, to Wednesday morning. He said that unless senators can agree to a "finite list of amendments" to consider, the bill will continue to be delayed.

Sounding a pessimistic note on the Senate floor,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.